Menu
Thekabarnews.com Thekabarnews.com
  • Home
  • World
  • Indonesia
  • Biz & Tech
  • Islamic
  • Knowledge
  • Kabar Film
  • Kalbar
  • Opinion
  • Support Us
Thekabarnews.com Thekabarnews.com
Support Us
Login
  • Home
  • World
  • Indonesia
  • Biz & Tech
  • Islamic
  • Knowledge
  • Kabar Film
  • Kalbar
  • Opinion
  • Support Us
Let's Donate
Asset Forfeiture Law clears house after 18-year wait
Prabowo says APEC deals could reach $86.8 billion
Sherly, Amran or Anies: Who fits Indonesia’s VP role?
Home/Knowledge/A Single Injection Took The Place of a Lifetime’s Worth of Cholesterol Pills
Knowledge

A Single Injection Took The Place of a Lifetime’s Worth of Cholesterol Pills

Jakarta, thekabarnews.com – A big medical development means that people may not need to take cholesterol medicines every day in the future. Scientists have used CRISPR gene-editing technology...

Avishiena Arch
December 27, 2025 2 Min Read
411 0
A Single Injection Took The Place of a Lifetime's Worth of Cholesterol Pills

Jakarta, thekabarnews.com – A big medical development means that people may not need to take cholesterol medicines every day in the future. Scientists have used CRISPR gene-editing technology to permanently turn off a gene in the liver that makes too much cholesterol. A single injection changed the way the body controls cholesterol levels inside.

In early human trials, levels of LDL cholesterol plummeted by almost 50 percent. Additionally, levels of triglycerides declined by more than 55 percent. This treatment seems to last a long time, maybe even forever. This is unlike statins and other lipid-lowering medications that you have to take every day for the rest of your life. The intervention works by changing the DNA in liver cells. This changes the way cholesterol is made at its source.

This method does not just treat the symptoms. It also goes after the actual cause of high cholesterol. Once the gene is turned off, the liver spontaneously keeps lipid levels at a healthy range. This happens without the need for more medicine. Researchers think this method could greatly lower the risk of heart attacks and strokes over a person’s lifetime. This is especially true for people who have inherited or treatment-resistant cholesterol problems.

The effects go far beyond just cholesterol. These gene-editing techniques could potentially treat high blood pressure, type 2 diabetes, and other metabolic or cardiovascular illnesses. This could happen in the future. The development means that medicine is changing from treating chronic diseases. It is now fixing biological problems once.

Experts say the present is a turning moment in preventative medicine. However, more long-term safety data and bigger trials are still needed. A future in which a single therapy supplants decades of daily medication could radically transform healthcare expenditures. It could also change the methodology for addressing diseases at their source rather than their effects.

Conclusion

A major medical breakthrough suggests daily cholesterol meds may be unnecessary. Scientists used CRISPR gene editing to permanently silence a liver gene that produces too much cholesterol. 

After a single injection, early human trials showed approximately 50% LDL cholesterol reduction and over 55% triglyceride reduction. This medication may permanently alter liver cell DNA to treat excessive cholesterol. 

Researchers believe it could considerably lower heart attack and stroke chances, especially in hereditary or treatment-resistant cholesterol patients. Similar gene-editing methods could treat high blood pressure and type 2 diabetes, not just cholesterol. Experts believe this will alter preventative medicine, but more long-term safety data and larger trials are needed.

Tags:

cholesterolFeaturedHealthNewsresearch

Share Article

Using your phone before bed can have a big effect on your brain
Previous Post

Using your phone before bed can have a big effect on your brain

This is a Story about Jesus in Japan Who has Married a Farmer's Daughter
Next Post

This is a Story about Jesus in Japan, Who has Married a Farmer’s Daughter

No Comment! Be the first one.

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Follow
34,470
fans
12,000
followers
8,200
join
50,654
subscribe
Hashim leads COP31 diplomacy as Indonesia secures Rp1.8tn | The Kabar News
Hashim leads COP31 diplomacy as Indonesia...
Kang Nchus
West Kalimantan records 1,230 Chikungunya cases | The Kabar News
West Kalimantan records 1,230 Chikungunya cases
Avishiena Arch
Indonesian govt weighs vape ban amid narcotics findings | The Kabar News
Indonesian govt weighs vape ban amid...
Achmed Eirham
Ferry Irwandi fundraiser faces transparency test | The Kabar News
Ferry Irwandi fundraiser faces transparency test
Achmed Eirham
MPR names Bambang Pacul to lead VP selection panel | The Kabar News
MPR names Bambang Pacul to lead...
Kang Nchus
MPR names Bambang Pacul to lead VP selection panel | The Kabar News
MPR names Bambang Pacul to lead...
Kang Nchus
Indonesia delays vice presidential vote to Dec. 9 | The Kabar News
Indonesia delays vice presidential vote to...
Kang Nchus
BGN appoints ex-KPK officials to oversee MBG program | The Kabar News
BGN appoints ex-KPK officials to oversee...
Avishiena Arch
Prabowo: ASEAN-China ties need peace, shared growth | The Kabar News
Prabowo: ASEAN-China ties need peace, shared...
Avishiena Arch
Prabowo vows to defy pressure in economic reform push | The Kabar News
Prabowo vows to defy pressure in...
Kang Nchus

You Might Also Like

Asset Forfeiture Law clears house after 18-year wait | The Kabar News
Indonesia
Asset Forfeiture Law clears house after 18-year wait
By Achmed Eirham
Prabowo says APEC deals could reach $86.8 billion | The Kabar News
Indonesia
Prabowo says APEC deals could reach $86.8 billion
By Kang Nchus
Sherly, Amran or Anies: Who fits Indonesia’s VP role? | The Kabar News
Knowledge
Sherly, Amran or Anies: Who fits Indonesia’s VP role?
By Achmed Eirham
Indonesia-China MoUs target $71.8bn in projects | The Kabar News
Indonesia
Indonesia-China MoUs target $71.8bn in projects
By Kusnadi Assaini
Thekabarnews.com Thekabarnews.com

Links

  • Home
  • Advertise
  • Support Us

Contact

  • About
  • Contact
  • Editorial

Follow

Instagram
Tiktok
Facebook

Our Policy

  • Cyber Media Guidelines
  • Correction Policy
  • AI Policy
Sign Up for Free and be the First to Get Notified About New Posts.
Copyright © 2026 - thekabarnews, All Right Reserved
  • Privacy Policy
  • Code Ethics
  • Disclaimer